Collegium Pharmaceutical Inc (COLL)
32.44
-1.23
(-3.65%)
USD |
NASDAQ |
May 17, 16:00
32.44
0.00 (0.00%)
After-Hours: 20:00
Collegium Pharmaceutical SG&A Expense (Quarterly): 41.98M for March 31, 2024
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 41.98M |
December 31, 2023 | 32.94M |
September 30, 2023 | 35.30M |
June 30, 2023 | 38.19M |
March 31, 2023 | 52.78M |
December 31, 2022 | 38.03M |
September 30, 2022 | 38.37M |
June 30, 2022 | 41.25M |
March 31, 2022 | 54.53M |
December 31, 2021 | 26.60M |
September 30, 2021 | 30.51M |
June 30, 2021 | 30.37M |
March 31, 2021 | 31.48M |
December 31, 2020 | 26.82M |
September 30, 2020 | 26.43M |
June 30, 2020 | 29.32M |
March 31, 2020 | 31.26M |
December 31, 2019 | 25.09M |
September 30, 2019 | 30.07M |
June 30, 2019 | 28.94M |
March 31, 2019 | 32.35M |
Date | Value |
---|---|
December 31, 2018 | 30.45M |
September 30, 2018 | 33.45M |
June 30, 2018 | 31.28M |
March 31, 2018 | 31.58M |
December 31, 2017 | 25.09M |
September 30, 2017 | 22.76M |
June 30, 2017 | 22.06M |
March 31, 2017 | 22.85M |
December 31, 2016 | 25.37M |
September 30, 2016 | 23.57M |
June 30, 2016 | 20.17M |
March 31, 2016 | 11.52M |
December 31, 2015 | 7.905M |
September 30, 2015 | 5.907M |
June 30, 2015 | 2.934M |
March 31, 2015 | 2.185M |
December 31, 2014 | 1.02M |
September 30, 2014 | 0.687M |
June 30, 2014 | 0.523M |
March 31, 2014 | 0.475M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
25.09M
Minimum
Dec 2019
54.53M
Maximum
Mar 2022
34.51M
Average
31.37M
Median
SG&A Expense (Quarterly) Benchmarks
Catalyst Pharmaceuticals Inc | 46.94M |
Supernus Pharmaceuticals Inc | 86.52M |
AnaptysBio Inc | 12.34M |
Recursion Pharmaceuticals Inc | 31.41M |
Nuvalent Inc | 13.95M |